HIGHLIGHTS
- who: M. Benavides from the Biology Laboratory (CIMES), University of Mu00e1laga, Mu00e1lagaCIBERONC, Mu00e1laga, Spain have published the article: Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer, in the Journal: (JOURNAL) of 22/03/2018
- what: The authors report the ability of each test to identify unselected patients and turnaround time (TAT) in real-world clinical practice. In this prospective study, the authors demonstrate that comprehensive ctDNA testing identifies at least as many patients with guideline-recommended biomarkers as SOC tissue . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.